Pharmaceutical Executive Daily: Johnson & Johnson Separating Its Orthopedics Unit
Oct 15, 2025
02:47
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
In today’s Pharmaceutical Executive Daily, we explore Johnson & Johnson’s plan to separate its orthopaedics division into a standalone company, the global implications of the Most Favored Nation drug pricing proposal, and strategies helping small biotechs reach market faster.
Pharmaceutical Executive